首页> 美国卫生研究院文献>Journal of Applied Clinical Medical Physics >In vivo dosimetry using a single diode for megavoltage photon beam radiotherapy: Implementation and response characterization
【2h】

In vivo dosimetry using a single diode for megavoltage photon beam radiotherapy: Implementation and response characterization

机译:使用单个二极管进行兆伏光子束放射疗法的体内剂量测定:实现和响应表征

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The AAPM Task Group 40 reported that in vivo dosimetry can be used to identify major deviations in treatment delivery in radiation therapy. In this paper, we investigate the feasibility of using one single diode to perform in vivo dosimetry in the entire radiotherapeutic energy range regardless of its intrinsic buildup material. The only requirement on diode selection would be to choose a diode with the adequate build up to measure the highest beam energy. We have tested the new diodes from Sun Nuclear Corporation (called QED and ISORAD‐p–both p‐type) for low‐, intermediate‐, and high‐energy range. We have clinically used both diode types to monitor entrance doses. In general, we found that the dose readings from the ISORAD (p‐type) are closer of the dose expected than QED diodes in the clinical setting. In this paper we report on the response of these newly available ISORAD (p‐type) diode detectors with respect to certain radiation field parameters such as source‐to‐surface distance, field size, wedge beam modifiers, as well as other parameters that affect detector characteristics (temperature and detector‐beam orientation). We have characterized the response of the high‐energy ISORAD (p‐type) diode in the low‐ (1–4 MV), intermediate‐ (6–12 MV), and high‐energy (15–25 MV) range. Our results showed that the total variation of the response of high‐energy ISORAD (p‐type) diodes to all the above parameters are within ±5% in most encountered clinical patient treatment setups in the megavoltage photon beam radiotherapy. The usage of the high‐energy buildup diode has the additional benefit of amplifying the response of the diode reading in case the wrong energy is used for patient treatment. In the light of these findings, we have since then switched to using only one single diode type, namely the “red” diode; manufacturer designation of the ISORAD (p‐type) high‐energy (15–25 MV) range diode, for all energies in our institution and satellites.PACS number(s): 87.66.–a, 87.53.–j
机译:AAPM任务组40报告说,体内剂量测定法可用于确定放射治疗中治疗的主要偏差。在本文中,我们研究了使用单个二极管在整个放射治疗能量范围内进行体内剂量测定的可行性,无论其固有的堆积材料如何。对二极管选择的唯一要求是选择一个具有足够结构以测量最高束能量的二极管。我们已经测试了Sun Nuclear Corporation的新型二极管(分别称为QED和ISORAD-p-p型),适用于低,中和高能量范围。我们已经在临床上使用了两种二极管类型来监控进入剂量。通常,我们发现在临床环境中,ISORAD(p型)的剂量读数比QED二极管的预期剂量更近。在本文中,我们报告了这些新型可用的ISORAD(p型)二极管检测器对某些辐射场参数(例如源到表面距离,场大小,楔形束修改器以及其他影响辐射场参数)的响应。检测器特性(温度和检测器光束方向)。我们已经在低(1-4 MV),中(6-12 MV)和高能量(15-25 MV)范围内表征了高能ISORAD(p型)二极管的响应。我们的结果表明,在兆伏光子束放射疗法中,大多数临床患者治疗设置中,高能ISORAD(p型)二极管对上述所有参数的响应总变化在±5%以内。如果患者使用了错误的能量,则使用高能量积聚二极管还有一个额外的好处,就是可以放大二极管读数的响应。根据这些发现,从那时起,我们已切换到仅使用一种二极管类型,即“红色”二极管。 ISORAD(p型)高能(15-25 MV)范围二极管的制造商名称,适用于我们机构和卫星中的所有能量。PACS编号:87.66.–a,87.53.–j

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号